Related Experiment Videos
Atezolizumab in "Real World" Patients: Do Phase 3b Trials Help Bridge the Gap Between Efficacy and Effectiveness?
Vaibhav G Patel1, Matthew D Galsky1
1Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
European Urology
|April 23, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer.
The New England journal of medicine·2026
Additivity, Not Synergy, Underlies the Efficacy of Current Combination Regimens in Urothelial Cancer.
Cancer research communications·2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.
Future oncology (London, England)·2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Silencing GJB2 attenuates IL-1β-induced chondrocyte injury by activating Nrf2/HO-1 signaling and preserving mitochondrial function.
Folia histochemica et cytobiologica·2026
DPM2 promotes melanoma progression and serves as a prognostic factor.
Melanoma research·2026
Efficacy of combined atorvastatin and paromomycin in treating experimental cryptosporidiosis in immunosuppressed mice.
QJM : monthly journal of the Association of Physicians·2026
Pan-RAS Inhibitor Shows Activity in Advanced Lung Cancer.
Cancer discovery·2026